Clinical Trials
2 trialsNCT02101918 2020-03-23
Ziv-Aflibercept in Treating and Computed Tomography Perfusion Imaging in Predicting Response in Patients With Pancreatic Neuroendocrine Tumors That Are Metastatic or Cannot Be Removed by Surgery
National Cancer Institute (NCI)
Phase 2 Completed
NCT01163526 2017-01-30
Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies
Stanford University
Terminated